TNF Pharmaceuticals, Inc.
(NASDAQ) QCLS
TNF Pharmaceuticals, Inc. Financials at a Glance
Market Cap
$26.70M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.80M
EPS (TTM)
$-149.63
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$3.49
Volume
196,113.369
Open
$3.29
Price
$3.49
Volume
196,113.369
Open
$3.29
Previous Close
$3.40
Daily Range
$3.25 - $3.52
52-Week Range
$2.50 - $44.00
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$3.49
Volume
196,113.369
Open
$3.29
Previous Close
$3.40
Daily Range
$3.25 - $3.52
52-Week Range
$2.50 - $44.00
QCLS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TNF Pharmaceuticals, Inc.
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Christopher C. Chapman, Jr., MD
Website
tnfpharma.comHeadquarters
New York, NY 10036, US
QCLS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-41%
Return on Capital
-27%
Return on Assets
-21%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$26.70M
Shares Outstanding
7.85M
Volume
196.11K
Short Interest
0.00%
Avg. Volume
1.14M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$10.17M
EBITDA
$8.66M
Operating Cash Flow
$8.98M
Capital Expenditure
$0.00
Free Cash Flow
$8.98M
Cash & ST Invst.
$8.52M
Total Debt
$10.58K
TNF Pharmaceuticals, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$26.70M
N/A
Market Cap/Employee
$4.45M
N/A
Employees
6
N/A
Net Income
$2.81M
-45.7%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$10.00M
-5.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-20.94%
N/A
Return on Invested Capital
-27.11%
N/A
Free Cash Flow
$1.16M
+69.4%
Operating Cash Flow
$1.16M
+69.4%